SNDX-5613
Showing 1 - 17 of 17
Relapsed/Refractory Acute Leukemia Trial (SNDX-5613)
Available
- Relapsed/Refractory Acute Leukemia
- SNDX-5613
- (no location specified)
Jun 15, 2023
Colorectal Cancer, Solid Tumors Trial (SNDX-5613, Chemotherapy)
Not yet recruiting
- Colorectal Cancer
- Solid Tumors
- SNDX-5613
- Chemotherapy
- (no location specified)
Feb 15, 2023
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023
Acute Myeloid Leukemia Trial in Houston (SNDX-5613)
Recruiting
- Acute Leukemia
- SNDX-5613
-
Houston, TexasMD Anderson Cancer Center
Oct 3, 2022
Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)
Recruiting
- Acute Myeloid Leukemia
- SNDX-5613
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2022
Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati
Recruiting
- Relapsed/Refractory Leukemias
- +4 more
- SNDX-5613
- +2 more
-
Kansas City, Missouri
- +1 more
Jul 18, 2022
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
Not yet recruiting
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Biospecimen Collection
- +12 more
- (no location specified)
Mar 8, 2023
Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)
Recruiting
- Previously Untreated Acute Myeloid Leukemia
- Samalizumab (BAML-16-001-S1)
- +32 more
-
Phoenix, Arizona
- +18 more
Oct 17, 2022
Unresectable Intrahepatic Cholangiocarcinoma Trial in Baltimore (Durvalumab, SNDX-6352)
Active, not recruiting
- Unresectable Intrahepatic Cholangiocarcinoma
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Jan 10, 2023
Chronic Graft-versus-host-disease Trial in United States (SNDX-6352)
Active, not recruiting
- Chronic Graft-versus-host-disease
-
Birmingham, Alabama
- +10 more
Aug 18, 2022
Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung Trial in United States (Entinostat, Placebo, Erlotinib)
Completed
- Non-Small-Cell Lung Carcinoma
- Carcinoma, Non-Small Cell Lung
- Entinostat
- +2 more
-
Tucson, Arizona
- +29 more
Aug 18, 2022
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma Trial in United States (Azacitidine, Entinostat,
Terminated
- Stage IA Non-Small Cell Lung Carcinoma
- Stage IB Non-Small Cell Lung Carcinoma
- Azacitidine
- +2 more
-
Los Angeles, California
- +8 more
Jan 14, 2019